Search Results
Sep 23, 2025, 08:36 ET CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March
More news about: Berger Montague
Sep 22, 2025, 11:41 ET Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 2-DAY DEADLINE in Securities Lawsuit- Hagens Berman
Importantly, (1) investors who purchased Spectrum (SPPI) common shares on the open market during the Class Period and (2) investors who acquired Spectrum (SPPI) common shares during the Class Period and later received shares of Assertio Holdings (ASRT) pursuant
More news about: Hagens Berman Sobol Shapiro LLP
Sep 22, 2025, 04:26 ET SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by
More news about: The Schall Law Firm
Sep 20, 2025, 14:00 ET SPPI Deadline: SPPI Investors with Losses in Excess of $100K Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between May 12, 2022 and September 22, 2022, both dates inclusive (the "Class Period"),
More news about: THE ROSEN LAW FIRM, P. A.
Sep 20, 2025, 10:54 ET Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 4-DAY DEADLINE in Securities Lawsuit- Hagens Berman
Importantly, (1) investors who purchased Spectrum (SPPI) common shares on the open market during the Class Period and (2) investors who acquired Spectrum (SPPI) common shares during the Class Period and later received shares of Assertio Holdings (ASRT) pursuant
More news about: Hagens Berman Sobol Shapiro LLP
Sep 18, 2025, 17:34 ET Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 6-DAY DEADLINE in Securities Lawsuit- Hagens Berman
Importantly, (1) investors who purchased Spectrum (SPPI) common shares on the open market during the Class Period and (2) investors who acquired Spectrum (SPPI) common shares during the Class Period and later received shares of Assertio Holdings (ASRT) pursuant
More news about: Hagens Berman Sobol Shapiro LLP
Sep 16, 2025, 18:03 ET Spectrum (SPPI) Securities Lawsuit Seeks New Lead Plaintiff - Hagens Berman
SPPI Investors with Losses Encouraged to Contact Hagens Berman Before Sept. 24th Deadline SAN FRANCISCO, Sept.
More news about: Hagens Berman Sobol Shapiro LLP
Sep 15, 2025, 03:39 ET Spectrum Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPPI
or "the Company") (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SPPI during the class period listed
More news about: DJS Law Group LLP
Sep 15, 2025, 02:34 ET SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by
More news about: The Schall Law Firm
Sep 12, 2025, 11:51 ET DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March
More news about: Berger Montague
Sep 11, 2025, 17:18 ET Spectrum (SPPI) Securities Lawsuit Seeks New Lead Plaintiff - Hagens Berman
SPPI Investors with Losses Encouraged to Contact Hagens Berman Before Sept. 24th Deadline SAN FRANCISCO, Sept. 11, 2025
More news about: Hagens Berman Sobol Shapiro LLP
Sep 10, 2025, 18:17 ET SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between May 12, 2022 and September 22, 2022, both dates inclusive (the "Class Period"),
More news about: THE ROSEN LAW FIRM, P. A.